Fig. 1From: Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from GermanyFlow-chart of included patients. CGRP (-R) mAb: Calcitonin gene-related peptide (-receptor) monoclonal antibodyBack to article page